Manchester United star Diogo Dalot has invested 拢840,000 into London-based HealthTech Bioniq.聽
The full-back, who has been a Manchester United regular in the past few seasons, joins his former United team-mate and current international captain Cristiano Ronaldo, who is among the firm鈥檚 shareholders after investing last year.聽
Bioniq is a developer of personalised nutritional supplements based on blood biomarker data and Dalot has been integrating the firm鈥檚 formulas into his diet over the past three years before deciding to invest.聽
The news comes after the company raised 拢11.5m in Series B funding last July to expand its global market share.聽
Dalot鈥檚 investment will be used to help the 2019-founded firm accelerate its growth but it also increases its credibility and is a useful marketing tool.聽
Diary of a CEO Mum: Is this Steven Bartlett’s greatest hire?
鈥淒iogo has an exceptional approach to performance optimisation and recovery, constantly seeking the most effective and scientifically backed methods to enhance his physical and cognitive capabilities,鈥� said Bioniq founder and CEO Vadim Fedotov.聽
鈥淗is dedication to craft and commitment to maximising potential makes him a perfect fit for Bioniq. He shares our vision and mission, recognising that the future of health lies in precision, personalisation, and efficacy.鈥澛�
Dalot added: 鈥�When it comes to high-level performance, my biggest focus has always been finding that extra 1 per cent 鈥� the key to setting myself apart from the rest.聽
鈥淪ince discovering Bioniq in 2022, it鈥檚 been a game-changer for me. I’ve seen the results for myself. Achieving such progress is only possible with a product that鈥檚 truly personalised and tailored specifically to my needs.
鈥淣ow, I鈥檓 thrilled to take the next step as an investor. I believe in Bioniq鈥檚 mission and see the tremendous potential of this business, especially with the growing global demand for personalised nutrition.鈥�